Results 161 to 170 of about 58,192 (237)

Acute Periflexural Purpura as a Revealing Sign of Parvovirus B19 Infection in a Child. [PDF]

Cureus
Mernissi Z, Aboudourib M, Bendaoud L, Hocar O, Amal S.   +4 more
europepmc   +1 more source

Púrpura de Shönlein-Henoch en el curso de trombocitopenia inmune primaria crónica. Presentación de un caso

, 2019
La púrpura de Shönlein-Henoch es una vasculitis de la infancia caracterizada por una púrpura palpable no trombocitopénica y manifestaciones sistémicas, acompañadas de dolor abdominal, sangrado gastrointestinal, glomerulonefritis, artritis y artralgias ...
Lucía Díaz Morejón, Belkis Lázara Rodríguez Jorge, Dumeivy García Sánchez   +2 more
core  

Disease Remission: A Scoping Review With Thematic Analysis of the Scientific Literature With Implications for Chronic Rhinosinusitis

International Forum of Allergy &Rhinology, Volume 16, Issue 6, Page 615-629, June 2026.
ABSTRACT Background Remission, a term used to describe a goal of treatment for some chronic diseases, has recently been proposed for chronic rhinosinusitis (CRS). However, it is unclear what remission means for CRS and why it should serve as a goal in the present‐day treatment of CRS.
Nikhil Parail, Lynn Warner, Stacey T. Gray, Claire Hopkins, Peter H. Hwang, Sarah K. Wise, Katie M. Phillips, Ahmad R. Sedaghat   +7 more
wiley   +1 more source

Complication after knee intra-articular betamethasone injection, a thrombocytopenic purpura: a case report. [PDF]

J Med Case Rep
Fauny M, Fresse A, Loeuille D, Chary-Valckenaere I.   +3 more
europepmc   +1 more source

Interleukin‐5, Eosinophils, and Interleukin‐5 Pathway Inhibitors in Eosinophilic Granulomatosis With Polyangiitis

Arthritis &Rheumatology, Volume 78, Issue 6, Page 1196-1205, June 2026.
Interlukin‐5 (IL‐5) plays a crucial role in the pathogenesis of eosinophilic granulomatosis with polyangiitis (EGPA) by promoting eosinophil differentiation, activation, and survival. We present here a typical case of EGPA in which treatment with IL‐5 pathway inhibitors is prescribed, showing to be beneficial for the patient.
Alvise Berti, Christian Pagnoux
wiley   +1 more source

Purpura thrombopénique thrombotique immunologique chez un homme de 35 ans présentant des urines foncées. [PDF]

CMAJ
Bhangu G, Arreglo R, Merkeley H.
europepmc   +1 more source

Single‐Cell RNA Sequencing Informs Precision Targeting of Monogenic Lupus Associated With IKZF1 Haploinsufficiency

Arthritis &Rheumatology, Volume 78, Issue 6, Page 1231-1244, June 2026.
Objective This study aimed to investigate the mechanisms of immune dysregulation in a pediatric patient with monogenic lupus driven by IKZF1 haploinsufficiency. Methods Peripheral immune cells from a patient with IKZF1 haploinsufficiency, patients with lupus with no currently known genetic mutations, and healthy controls were analyzed using single‐cell
Qi Zheng, Yejun Tan, Zhaoling Wang, Yanjie Qian, Qian Ma, Danping Shen, Meiping Lu   +6 more
wiley   +1 more source

Epidemiology of immune-mediated thrombotic thrombocytopenic purpura in Germany. [PDF]

Res Pract Thromb Haemost
Schönermarck U, Wehrmann F, Schneider J, Fischereder M, von Bergwelt-Baildon A.   +4 more
europepmc   +1 more source

Neonatal Wet Gangrene With Early Auto‐Amputation in a Resource‐Limited Setting With Incomplete Etiologic Workup: A Case Report

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Neonatal limb gangrene with auto‐amputation is rare and often idiopathic. Early recognition, prompt referral, and thorough etiologic workup—despite resource limitations—are critical. Wet gangrene requires broad‐spectrum antibiotics, wound care, and timely surgical amputation to preserve growth plates and allow future prosthesis fitting.
Milki Tufa Feyisa, Beza Eshetu, Tolosa Dibisa, Mulatu Gshaw, Birhanu Tolera, Endalew Dessie Birara, Adugna Lamessa, Tamirat Godebo Woyimo   +7 more
wiley   +1 more source

Assessment of cardiovascular disease in immune thrombotic thrombocytopenic purpura. [PDF]

Res Pract Thromb Haemost
Evangelidis P, Kotsiou N, Kalmoukos P, Gavriilaki E.   +3 more
europepmc   +1 more source